
Releases
IDBS and Alchemi Link AI Agents to Regulated Biopharma Data
Biopharma firms face a persistent bottleneck in regulatory filings, where teams spend months manually assembling data. IDBS and Alchemi are now partnering to address this by integrating AI agents directly into the IDBS Polar platform, allowing for the automated drafting of submission dossiers while maintaining strict 21 CFR Part 11 compliance.
























